Dose-Response Effects of P Radioactive Stents in an Atherosclerotic Porcine Coronary Model
نویسندگان
چکیده
Background—Experimental studies have demonstrated that P radioactive stents reduce neointimal formation at 28 days in porcine iliac and coronary arteries. Our objective was to determine the long-term dose-response effects of 1.0to 12.0-mCi P radioactive stents in a porcine atherosclerotic coronary model. Methods and Results—Control (n519) and 1.0to 12.0-mCi P radioactive (n543) stents (total, n562) were implanted in the coronary arteries of 31 miniature swine at 28 days after creation of a fibrocellular plaque by overstretch balloon injury and cholesterol feeding. Angiography and histomorphometry were performed at 6 months. Stent thrombosis occurred in 3 radioactive (7.7%) and no control stents (P50.54). On histology, the mean neointimal area and the percent in-stent stenosis correlated positively with increasing stent activity (r50.64, P,0.001). The mean neointimal area (mm) for the stents with $3.0 mCi P (3.5761.21) was significantly greater than that for the nonradioactive stents (1.7860.68, P,0.0001). The neointima of the stents with $3.0 mCi P was composed of smooth muscle cells, matrix proteoglycans, calcification, foam cells, and cholesterol clefts. Conclusions—Continuous low-dose-rate irradiation delivered by high-activity P radioactive stents promotes the formation of an “atheromatous” neointima after 6 months in this experimental model. These data may be useful for predicting late tissue responses to radioactive stents in human coronary arteries. (Circulation. 1999;100:1548-1554.)
منابع مشابه
Dose-response effects of 32P radioactive stents in an atherosclerotic porcine coronary model.
BACKGROUND Experimental studies have demonstrated that 32P radioactive stents reduce neointimal formation at 28 days in porcine iliac and coronary arteries. Our objective was to determine the long-term dose-response effects of 1.0- to 12.0-microCi 32P radioactive stents in a porcine atherosclerotic coronary model. METHODS AND RESULTS Control (n=19) and 1.0- to 12.0-microCi 32P radioactive (n=...
متن کامل"Edge Effect" of (32)p radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff.
BACKGROUND Radioactive stents have been reported to reduce in-stent neointimal thickening. An unexpected increase in neointimal response was observed, however, at the stent-to-artery transitions, the so-called "edge effect." To investigate the factors involved in this edge effect, we studied stents with 1 radioactive half and 1 regular nonradioactive half, thereby creating a midstent radioactiv...
متن کامل“Edge Effect” of P Radioactive Stents Is Caused by the Combination of Chronic Stent Injury and Radioactive Dose Falloff
Background—Radioactive stents have been reported to reduce in-stent neointimal thickening. An unexpected increase in neointimal response was observed, however, at the stent-to-artery transitions, the so-called “edge effect.” To investigate the factors involved in this edge effect, we studied stents with 1 radioactive half and 1 regular nonradioactive half, thereby creating a midstent radioactiv...
متن کاملDosimetric comparison between four kinds of radioactive esophageal stents to be used in the treatment of advanced esophageal cancers using Monte Carlo simulation
Finding accurate methods to be employed for the treatment of esophageal cancers is of especial interest for researchers, due to the sensitivity of this tissue. Recently radioactive stents loaded with I-125 brachytherapy seeds have been widely investigated for the treatment of advanced esophageal cancer. It is necessary to investigate the dose distribution of any radioactive esophageal stents be...
متن کاملPaclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
BACKGROUND Despite limiting elastic recoil and late vascular remodeling after angioplasty, coronary stents remain vulnerable to restenosis, caused primarily by neointimal hyperplasia. Paclitaxel, a microtubule-stabilizing drug, has been shown to inhibit vascular smooth muscle cell migration and proliferation contributing to neointimal hyperplasia. We tested whether paclitaxel-coated coronary st...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 1999